Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Clinical trial NCT00589784 · COMPLETED

Trial details

NCT number: NCT00589784
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

CNS Cancer Meningioma Intracranial Hemangiopericytoma Hemangioblastoma Neurofibromatosis

Start date: 2007-10-01
Primary completion: 2014-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.